ABVC Biopharma Inc (ABVC) Up 3.57% in Premarket Trading

ABVC Biopharma Inc (ABVC) has risen Thursday morning, with the stock increasing 3.57% in pre-market trading to 1.16. ABVC's short-term technical score of 31 indicates that the stock has traded less bullishly over the last month than 69% of stocks on the market. In the Biotechnology industry, which ranks 130 out of 146 industries, the stock ranks higher than 48% of stocks. ABVC Biopharma Inc has risen 31.76% over the past month, closing at $0.88 on October 12. During this period of time, the stock fell as low as $0.85 and as high as $3.35. The company has an average price target of $20.20.

ABVC has an Overall Score of 17. Find out what this means to you and get the rest of the rankings on ABVC!

See Full ABVC Report

ABVC Biopharma Inc has a Long-Term Technical rank of 21. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 79% of the market scoring higher. In the Biotechnology industry which is number 124 by this metric, ABVC ranks better than 124% of stocks.

Important Dates for Investors in ABVC:

-ABVC Biopharma Inc is set to release earnings on 2023-11-13. Over the last 12 months, the company has reported EPS of $-0.98. -We do not have a set dividend date for ABVC Biopharma Inc at this time. Click Here To Get The Full Report on ABVC Biopharma Inc (ABVC)